The Age of Diagnosis: How Our Obsession With Medical Labels Is Making US Sicker - Hardcover

O'Sullivan, Suzanne, Dr.

Hardcover

ISBN 10: 0593852915 ISBN 13: 9780593852910

Verlag: Thesis, 2025

Inhaltsangabe

From a neurologist and the award-winning author of The Sleeping Beauties, a meticulous and compassionate exploration of how our culture of medical diagnosis can harm, rather than help, patients.

We live in an age of diagnosis. Conditions like ADHD and autism are on the rapid rise, while new categories like long Covid are being created. Medical terms are increasingly used to describe ordinary human experiences, and the advance of sophisticated genetic sequencing techniques means that even the healthiest of us may soon be screened for potential abnormalities. More people are labeled "sick" than ever before—but are these diagnoses improving their lives?

With scientific authority and compassionate storytelling, neurologist Suzanne O'Sullivan argues that our obsession with diagnosis is harming more than helping. It is natural when we are suffering to want a clear label, understanding, and, of course, treatment. But our current approach to diagnosis too often pathologizes difference, increases our anxiety, and changes our experience of our bodies for the worse.

Through the moving stories of real people, O'Sullivan compares the impact of a medical label to the pain of not knowing. She explains the way the boundaries of a diagnosis can blur over time. Most importantly, she calls for us to find new and better vocabularies for suffering and to find ways to support people without medicalizing them.

Über diesen Titel

Über die Autorin bzw. den Autor

Dr. Suzanne O'Sullivan has been a consultant neurologist and clinical neurophysiologist since 2004, specializing in complex epilepsy and functional neurological disorders. She is the author of three books: It’s All in Your Head, which won the 2016 Wellcome Book Prize and the Royal Society of Biology general book prize, Brainstorm, and The Sleeping Beauties, which was shortlisted for the Royal Society book prize and for the Next Big Ideas club.

Auszug. © Genehmigter Nachdruck. Alle Rechte vorbehalten.

One

Huntington's Disease

'If you were going to be knocked down by a bus tomorrow, you wouldn't want to know, would you?' Valentina asked.

'I would want to know,' I decided. 'I'd spend a lot of time talking to people and then I'd eat everything off the menu in the Ritz!'

We were both laughing but we were also aware that Valentina knew better. Valentina's mother has the genetically determined neurological condition Huntington's disease (HD) and Valentina faced a 50% chance that she had inherited the disorder. She had spent years considering whether or not to be tested, weighing all the pros and cons of having advanced knowledge of a big slice of her medical future. A predictive genetic test could give her some sense of certainty-but, like all predictive diagnostic tests, it would also create a cascade of consequences that many fail to anticipate.

Predictive medicine is diagnosis in healthy people before a disease has had a chance to start. Genetic predictive diagnosis can be used to advise people of a pending health problem decades ahead of time. That means many years of waiting and watching for the first symptom to strike.

Huntington’s disease is an incurable condition that causes progressive physical and cognitive disability. The early signs are often subtle behavioural changes such as mood swings, social withdrawal, loss of impulse control and poor organisation. Psychiatric features are prominent. Depression, mania, obsessive behaviour, and thoughts of death and suicide may feature. Motor symptoms can be present early on but more often come later, resulting in clumsiness, loss of balance, slurred speech and difficulty swallowing. A hallmark of the disease is the development of jerky involuntary muscle twitches called chorea or choreiform movements. In the later stages, sufferers are unable to walk and struggle to eat or speak. Nothing will stop the downhill trajectory to severe disability. The typical age of onset of symptoms is between thirty and fifty, with the eventual death coming roughly ten to twenty-five years later. The first disease gene to be discovered was that for Huntington’s disease. More than anyone else, the HD community understand the gravity of the decision to take a predictive diagnostic test.

Human DNA is arranged into twenty-three chromosome pairs. One pair are sex chromosomes, X and Y, and the other twenty-two numbered pairs are referred to as autosomal. Genes, which make up small sections of the long threads of DNA within a chromosome, are the basic unit of inheritance. They contain all the instructions needed for human development. Genes make proteins which make cells, and we are made of cells. When a gene code contains some form of mistake, a genetic disease can develop. Mistakes in genes were once called mutations but are now called variants.

As soon as the normal structure of DNA was understood, the search for genetic variants that cause disease could begin. The precise faulty gene that causes HD was identified in 1993. It is a monogenic disorder, meaning it's caused by a mistake in only one gene. Polygenic disorders, on the other hand, have contributions from multiple genes. HD is autosomal dominant, so the disease gene is on a numbered autosomal chromosome-chromosome 4-and only one gene in a pair needs to be a disease gene for HD to develop. Monogenic dominant disorders like HD have predictable inheritance because children either get the genetic variant from their affected parent or they don't: a fifty-fifty chance. The HD gene variant is not just a risk factor suggesting that a person might get HD, it is a certainty. The only question is when the symptoms will start and how quickly they will progress.

The discovery of the HD variant brought testing for Huntington's disease into everyday medical practice. From that moment on, any person with a family history of HD could be tested to see if they were also destined to develop the condition. It was clinical medicine's first opportunity to grapple with all the implications of giving healthy people a diagnosis of an impending incurable disease.

Valentina was twenty-eight and pregnant with her first child when she learned her mother was being tested for Huntington’s disease. Valentina’s family had no idea this was on their horizon. Vivian, Valentina’s mother, was adopted. She was never told of any bleak medical secret in her biological family, so when, in her fifties, she started dropping things and developed tic-like muscle twitches and loss of balance, nobody recognised this as the start of HD. Much later, Valentina wondered if her mother’s symptoms actually began many years before. As Valentina remembers it, Vivian had been prone to depressive bouts for many years. She was easily flustered and bad at decision-making. These are exactly the sort of non-specific symptoms that herald the insidious onset of neurodegeneration. When they happened to Vivian, they were attributed to more ordinary mental health problems.

A brain scan was what first alerted Vivian's neurologist to the possibility of HD and the need to refer Vivian for a genetic test. Vivian didn't take the suggestion very seriously. She was sure that somebody in the adoption services would have told her that she had a parent with HD and because they didn't, she convinced herself it was not her diagnosis. Only later did the family learn that Vivian's father had spent years in a psychiatric institution. In the past, before HD was fully understood or easy to diagnose, some sufferers languished in psychiatric units without a diagnosis. Not knowing she was at risk, Vivian was absolutely certain her tests for HD would come back negative. She was so dismissive of the test that Valentina wasn't particularly concerned either and didn't even think to ask about the result.

The day that Vivian found out she had HD, Valentina's future and the future of her unborn child changed dramatically. All of Valentina's siblings' and nieces' and nephews' lives changed, too. Each of Vivian's four children went from being perfectly healthy young people to having a fifty-fifty chance that they would eventually develop an incurable neurodegenerative disease, while Vivian's grandchildren had an immediate 25% chance of being affected. The wife of Valentina's brother Luca was pregnant too, with their second child. Valentina's younger sister Camila was about to get married and had yet to start a family. The eldest of the siblings, Evangeline, already had three daughters and a son.

Vivian waited until Valentina's baby daughter, Ella, was born before they told her that the genetic test had been positive for HD. It came as a complete shock.

'I knew exactly what it meant when I heard about the diagnosis,' Valentina said, thinking back to that time. 'I like medical programmes and books. I'd heard of HD and I knew it was bad.' Vivian's symptoms had probably begun in her early forties. If Valentina had inherited the gene variant that causes HD, she would most likely start showing signs of the disease around the same age as her mother, giving her maybe another fifteen years of good health.

Vivian's diagnosis had an immediate impact on Valentina. She had always been a light-hearted, glass-half-full type of person, but she changed. She began having panic attacks. Before long, she needed antidepressants to control her mood and she has continued taking them since.

'When this is in the family, the children need to be prepared from a young age,' Valentina advised me. 'For us, there was no preparation and we all had so many decisions to make and so quickly.'

Valentina and her siblings were each at the point of starting or expanding their families. They were developing their careers, buying houses. Should they keep their plans the same or change them to accommodate the new possibility? Of the four children,...

Details zur Ausgabe

• Verlag: Thesis
• Erscheinungsdatum: 2025
• Sprache: Englisch
• ISBN 10: 0593852915
• ISBN 13: 9780593852910
• Einband: Gebundene Ausgabe
• Anzahl der Seiten: 298
• Kontakt zum Hersteller: Nicht verfügbar
• Verantwortliche Person: Buchbär; info@buchbaer.de; ; Weberstr. 67; Osnabrück; 49084; Deutschland